Taste Loss From a Breakthrough Myeloma Drug May Push Patients to Quit Therapy
A cross-sectional study of 32 multiple myeloma patients found that talquetamab caused taste disturbances in every participant, with impaired taste ...
A cross-sectional study of 32 multiple myeloma patients found that talquetamab caused taste disturbances in every participant, with impaired taste ...
A new first-person perspective in Advances in Therapy follows a music professor through repeated myeloma relapses to talquetamab therapy, revealing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine